Literature DB >> 18567705

Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury.

Katrina Go Yamazaki1, Diego Romero-Perez, Maraliz Barraza-Hidalgo, Michelle Cruz, Maria Rivas, Brenda Cortez-Gomez, Guillermo Ceballos, Francisco Villarreal.   

Abstract

Epidemiological studies have shown a correlation between flavonoid-rich diets and improved cardiovascular prognosis. Cocoa contains large amounts of flavonoids, in particular flavanols (mostly catechins and epicatechins). Flavonoids possess pleiotropic properties that may confer protective effects to tissues during injury. We examined the ability of epicatechin to reduce short-and long-term ischemia-reperfusion (I/R) myocardial injury. Epicatechin (1 mg.kg(-1).day(-1)) pretreatment (Tx) was administered daily via oral gavage to male rats for 2 or 10 days. Controls received water. Ischemia was induced via a 45-min coronary occlusion. Reperfusion was allowed until 48 h or 3 wk while Tx continued. We measured infarct (MI) size (%), hemodynamics, myeloperoxidase activity, tissue oxidative stress, and matrix metalloproteinase-9 (MMP-9) activity in 48-h groups. Cardiac morphometry was also evaluated in 3-wk groups. With 2 days of Tx, no reductions in MI size occurred. After 10 days, a significant approximately 50% reduction in MI size occurred. Epicatechin rats demonstrated no significant changes in hemodynamics. Tissue oxidative stress was reduced significantly in the epicatechin group vs. controls. MMP-9 activity demonstrated limited increases in the infarct region with epicatechin. By 3 wk, a significant 32% reduction in infarct size was observed with Tx, accompanied with sustained hemodynamics and preserved chamber morphometry. In conclusion, epicatechin Tx confers cardioprotection in the setting of I/R injury. The effects are independent of changes in hemodynamics, are sustained over time, and are accompanied by reduced levels of indicators of tissue injury. Results warrant the evaluation of cocoa flavanols as possible therapeutic agents to limit ischemic injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18567705      PMCID: PMC2519218          DOI: 10.1152/ajpheart.00413.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  45 in total

Review 1.  Myocardial reperfusion injury.

Authors:  Derek M Yellon; Derek J Hausenloy
Journal:  N Engl J Med       Date:  2007-09-13       Impact factor: 91.245

2.  Modes of myocardial cell injury and cell death in ischemic heart disease.

Authors:  L M Buja; M L Entman
Journal:  Circulation       Date:  1998-10-06       Impact factor: 29.690

Review 3.  Effect of plant flavonoids on immune and inflammatory cell function.

Authors:  E Middleton
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

4.  Antioxidants in chocolate.

Authors:  A L Waterhouse; J R Shirley; J L Donovan
Journal:  Lancet       Date:  1996-09-21       Impact factor: 79.321

5.  Structure-antioxidant activity relationships of flavonoids and phenolic acids.

Authors:  C A Rice-Evans; N J Miller; G Paganga
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

6.  Aging, acculturation, salt intake, and hypertension in the Kuna of Panama.

Authors:  N K Hollenberg; G Martinez; M McCullough; T Meinking; D Passan; M Preston; A Rivera; D Taplin; M Vicaria-Clement
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

Review 7.  Flavanols for cardiovascular health: the science behind the sweetness.

Authors:  Naomi D L Fisher; Norman K Hollenberg
Journal:  J Hypertens       Date:  2005-08       Impact factor: 4.844

8.  Reduction of myocardial infarct size by doxycycline: a role for plasmin inhibition.

Authors:  Michael O Griffin; Miki Jinno; Lindsey A Miles; Francisco J Villarreal
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

Review 9.  Cocoa antioxidants and cardiovascular health.

Authors:  Carl L Keen; Roberta R Holt; Patricia I Oteiza; César G Fraga; Harold H Schmitz
Journal:  Am J Clin Nutr       Date:  2005-01       Impact factor: 7.045

10.  28-Day oral (gavage) toxicity studies of green tea catechins prepared for beverages in rats.

Authors:  Christopher P Chengelis; Jeannie B Kirkpatrick; Karen S Regan; Ann E Radovsky; Melissa J Beck; Osamu Morita; Yasushi Tamaki; Hiroyuki Suzuki
Journal:  Food Chem Toxicol       Date:  2007-10-30       Impact factor: 6.023

View more
  37 in total

1.  Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction.

Authors:  Margarete Dulce Bagatini; Caroline Curry Martins; Vanessa Battisti; Diogo Gasparetto; Cintia Saydelles da Rosa; Roselia Maria Spanevello; Mushtaq Ahmed; Roberta Schmatz; Maria Rosa Chitolina Schetinger; Vera Maria Morsch
Journal:  Heart Vessels       Date:  2010-10-27       Impact factor: 2.037

2.  A chocolate a day keeps the doctor away?

Authors:  Christopher F Barnett; Teresa De Marco
Journal:  J Physiol       Date:  2011-12-15       Impact factor: 5.182

3.  Intravenous (-)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function.

Authors:  Katrina Go Yamazaki; Aleksander Y Andreyev; Pilar Ortiz-Vilchis; Susanna Petrosyan; Ajit S Divakaruni; Sandra E Wiley; Christine De La Fuente; Guy Perkins; Guillermo Ceballos; Francisco Villarreal; Anne N Murphy
Journal:  Int J Cardiol       Date:  2014-05-15       Impact factor: 4.164

4.  (-)-Epicatechin induces calcium and translocation independent eNOS activation in arterial endothelial cells.

Authors:  Israel Ramirez-Sanchez; Lisandro Maya; Guillermo Ceballos; Francisco Villarreal
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-05       Impact factor: 4.249

5.  Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion.

Authors:  Katrina Go Yamazaki; Pam R Taub; Maraliz Barraza-Hidalgo; Maria M Rivas; Alexander C Zambon; Guillermo Ceballos; Francisco J Villarreal
Journal:  J Am Coll Cardiol       Date:  2010-06-22       Impact factor: 24.094

6.  Elevated glutathione is not sufficient to protect against doxorubicin-induced nuclear damage in heart in multidrug resistance-associated protein 1 (Mrp1/Abcc1) null mice.

Authors:  Jun Deng; Donna Coy; Wei Zhang; Manjula Sunkara; Andrew J Morris; Chi Wang; Luksana Chaiswing; Daret St Clair; Mary Vore; Paiboon Jungsuwadee
Journal:  J Pharmacol Exp Ther       Date:  2015-09-09       Impact factor: 4.030

7.  Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.

Authors:  Wei Zhang; Jun Deng; Manjula Sunkara; Andrew J Morris; Chi Wang; Daret St Clair; Mary Vore
Journal:  J Pharmacol Exp Ther       Date:  2015-09-09       Impact factor: 4.030

8.  Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.

Authors:  Katsuyuki Tanabe; Yoshifuru Tamura; Miguel A Lanaspa; Makoto Miyazaki; Norihiko Suzuki; Waichi Sato; Yohei Maeshima; George F Schreiner; Francisco J Villarreal; Richard J Johnson; Takahiko Nakagawa
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-29

9.  (-)-Epicatechin is associated with increased angiogenic and mitochondrial signalling in the hindlimb of rats selectively bred for innate low running capacity.

Authors:  Maik Hüttemann; Icksoo Lee; Guy A Perkins; Steven L Britton; Lauren G Koch; Moh H Malek
Journal:  Clin Sci (Lond)       Date:  2013-06       Impact factor: 6.124

10.  (-)-Epicatechin rich cocoa mediated modulation of oxidative stress regulators in skeletal muscle of heart failure and type 2 diabetes patients.

Authors:  Israel Ramirez-Sanchez; Pam R Taub; Theodore P Ciaraldi; Leonardo Nogueira; Taylor Coe; Guy Perkins; Michael Hogan; Alan S Maisel; Robert R Henry; Guillermo Ceballos; Francisco Villarreal
Journal:  Int J Cardiol       Date:  2013-07-17       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.